Sidharth Ray | Pharmacology | Elite Academic Visionary Award

Published on by International Popular Scientist Awards

Elite Academic Visionary Award

Sidharth Ray
Touro University College of Pharmacy

Sidharth Ray
Affiliation Touro University College of Pharmacy
Country United States
Google Scholar ID 6qkMgcgAAAAJ
Documents 356
Citations 10,089
h-index 47
Subject Area Pharmacology
Event International Popular Scientist Awards
ORCID 0000-0001-8776-5513

Sidharth Ray is an academic researcher associated with Touro University College of Pharmacy in the United States, with a stated subject-area focus in pharmacology. The supplied academic profile records 356 documents, 10,089 citations, and an h-index of 47. His listed research record includes work addressing diabetes management, pharmacogenetics, insulin resistance, semaglutide and cardiovascular considerations, transplantation outcomes, and experimental toxicology. These publications provide a basis for considering the breadth and scholarly relevance of his research activity in relation to the Elite Academic Visionary Award.

Abstract

The Elite Academic Visionary Award profile recognizes the scholarly record presented for Sidharth Ray, whose stated academic affiliation is Touro University College of Pharmacy and whose principal subject area is pharmacology. The supplied metrics indicate 356 documents, 10,089 citations, and an h-index of 47. His documented publication portfolio spans pharmacological and biomedical topics including diabetes management, insulin resistance, pharmacogenetics, semaglutide, cardiovascular considerations, transplantation, and toxicology. Recent supplied records include a 2026 article examining etiological approaches to diabetes management and insulin resistance, a 2026 review concerning semaglutide and the heart, and a 2026 registry analysis of kidney transplantation in lithium nephrotoxicity. [1] [2] [3]

Keywords

Keywords: Sidharth Ray, pharmacology, pharmacogenetics, diabetes management, insulin resistance, semaglutide, cardiovascular pharmacology, transplantation, toxicology, pharmaceutical research, academic research, biomedical science, drug effects, clinical research, International Popular Scientist Awards.

Introduction

Pharmacology encompasses the study of drugs, their mechanisms of action, therapeutic applications, adverse effects, and interactions with biological systems. Research at the intersection of pharmacology and clinical medicine can address both therapeutic development and the evaluation of established interventions across diverse disease contexts. The publication records supplied for Sidharth Ray demonstrate involvement in several such areas, including metabolic disease, cardiovascular considerations, renal transplantation, and experimental toxicology.

Research Profile

The supplied profile identifies Sidharth Ray with Touro University College of Pharmacy and places his primary subject area within pharmacology. The stated bibliometric record comprises 356 documents, 10,089 citations, and an h-index of 47. These figures describe the supplied profile at the time of preparation and should be interpreted in the context of the indexing platform, author disambiguation, publication coverage, and the date on which the metrics were retrieved.

Research Contributions

The supplied publications indicate a multidisciplinary research profile within pharmacology and related biomedical fields. The themes represented in the records include metabolic disease, cardiovascular pharmacotherapy, renal transplantation, and toxicological protection.

  • Diabetes and insulin resistance: A 2026 article addresses diabetes management through an etiological perspective and discusses minimizing insulin resistance in connection with pharmacogenetics. [1]
  • Metabolic and cardiovascular pharmacology: A 2026 publication examines semaglutide and its relationship with cardiovascular considerations, contributing to discussion of the broader clinical context of glucagon-like peptide-1 receptor agonist therapy. [2]
  • Transplantation research: A 2026 registry analysis evaluates kidney transplantation for lithium nephrotoxicity and reports on graft and patient survival outcomes. [3]
  • Toxicological research: An earlier experimental publication investigated protection against drug- and chemical-induced multiorgan toxicity using an IH636 grape seed proanthocyanidin extract. [4]

Publications

The researcher’s publications span diabetes management, cardiovascular pharmacology, kidney transplantation, and drug-induced organ toxicity. Recent work explores pharmacogenetic approaches to reducing insulin resistance in diabetes, the complex cardiovascular effects of semaglutide, and outcomes of kidney transplantation for lithium nephrotoxicity. Earlier research investigated the protective effects of grape seed proanthocyanidin extract against drug- and chemical-induced multiorgan toxicity, demonstrating a broad research focus on therapeutic strategies and organ protection.

Research Impact

The supplied bibliometric figures of 10,089 citations and an h-index of 47 indicate that the profile has accumulated substantial citation activity across its indexed research output. The stated total of 356 documents further indicates a broad publication record. Such metrics are descriptive indicators of scholarly visibility and citation performance; they do not independently measure methodological quality, clinical effectiveness, societal benefit, or the significance of individual publications.1] [2] [3] The earlier toxicology study illustrates an additional experimental dimension of the supplied publication record. [4]

Award Suitability

For the purposes of the Elite Academic Visionary Award profile, the supplied record provides several documented dimensions for academic recognition: an established publication portfolio, substantial citation activity, a reported h-index of 47, and research spanning pharmacology and related biomedical disciplines. The recent publication record also demonstrates continued engagement with contemporary questions involving diabetes, insulin resistance, pharmacogenetics, semaglutide, cardiovascular considerations, and transplantation. [1] [2] [3]

Conclusion

Sidharth Ray’s supplied academic profile represents a substantial body of pharmacological and biomedical research, with 356 documents, 10,089 citations, and an h-index of 47. The selected publications demonstrate research activity involving diabetes management, pharmacogenetics, insulin resistance, semaglutide and cardiovascular considerations, kidney transplantation, and toxicological protection. [1] [2] [3] [4] Taken together, the supplied information provides a documented academic profile for consideration within the context of the Elite Academic Visionary Award and the International Popular Scientist Awards.

References

  1. Ray, Sidhartha D.; He, Lining Liang; Rottersmann, Stratton; Hand, Christina; Di Leo, Maria; Chunilall, Alec; Gray, Ian G.; Siu, Ngo Tsun; Jong, Sonia; Sirois, Nigel, et al. (2026). Shifting the Paradigm in Global Diabetes Management: Beyond Glycohemoglobinism and Toward Etiological Mitigation via Minimizing Insulin Resistance on the Basis of Pharmacogenetics. Diabetology, 7(9), 176.
    https://doi.org/10.3390/diabetology7090176
  2. Khan, Ezaan; Fernandes, Jessica; Gohel, Vishal; Jain, Rihi; Jayne, William; Peck, Colton; Shah, Tara S.; Shah, Radha S.; LaBarge, Judithe; Ray, Sidhartha D., et al. (2026). Semaglutide and the Heart: Focus on Their Love–Hate Relationship. Hearts, 7(3), 22.
    https://doi.org/10.3390/hearts7030022
  3. Cohen, Hannah; Toro, Deric; Zuluaga, Dayanna; Faddoul, Giovanni; Ray, Sidhartha D.; McAfee, Gavin; Ortiz, Alex Chiodo; Gillenwalters, Luke; Islam, Nashitah; Dean, Mary Ellen, et al. (2026). Kidney Transplantation for Lithium Nephrotoxicity is Associated With Noninferior Graft and Patient Survival: A National Donor-Stratified Registry Analysis. Clinical Transplantation.
    https://doi.org/10.1111/ctr.70563
  4. Bagchi, D.; Ray, S. D.; Patel, D.; Bagchi, M. (2001). Protection against drug- and chemical-induced multiorgan toxicity by a novel IH636 grape seed proanthocyanidin extract. Drugs under Experimental and Clinical Research.
    https://pubmed.ncbi.nlm.nih.gov/11276828/
  5. Google Scholar. Academic profile associated with Sidharth Ray, Google Scholar ID 6qkMgcgAAAAJ.
    https://scholar.google.com/citations?user=6qkMgcgAAAAJ&hl=en&oi=ao&cstart=0&pagesize=20

William Figg | Pharmacology | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

              William Figg
Affiliation National Cancer Institute
Country United States
Scopus ID 35377337900
Documents 883
Citations 48,614
h-index 115
Subject Area Pharmacology
Event International Popular Scientist Awards
ORCID 0000-0003-2428-5613

William Figg
National Cancer Institute

William Figg  the Best Researcher Award recognizes sustained excellence in scientific investigation, scholarly publication, and contributions to advancing biomedical knowledge. William Figg has established an extensive research profile in pharmacology and translational cancer research through a substantial body of peer-reviewed publications, collaborative investigations, and leadership in clinical pharmacology. His scholarly productivity, citation performance, and influence within the scientific community illustrate a significant contribution to evidence-based medicine and pharmaceutical sciences.[1]

Abstract

William Figg’s academic career reflects long-term engagement in pharmacology, oncology, and clinical translational research. His publication portfolio demonstrates continued contributions to drug development, pharmacokinetics, pharmacogenomics, and therapeutic optimization. His research output has supported scientific understanding while influencing clinical investigations and interdisciplinary collaborations.[1]

Keywords

Pharmacology, Clinical Pharmacology, Oncology Research, Drug Development, Translational Medicine, Precision Medicine, Cancer Therapeutics, Pharmacogenomics, Biomedical Research, Clinical Trials.

Introduction

Modern pharmacological research requires rigorous experimental design, interdisciplinary collaboration, and continuous translation of laboratory discoveries into clinical practice. William Figg has contributed extensively within these domains through investigations focusing on cancer therapeutics, drug metabolism, individualized medicine, and pharmacological innovation. His work has been disseminated through numerous internationally indexed journals and scientific collaborations.[2]

Research Profile

Affiliated with the National Cancer Institute, this distinguished researcher has authored 883 Scopus-indexed publications, received 48,614 citations, and achieved an h-index of 115. With primary expertise in pharmacology and cancer therapeutics, their impactful research has significantly advanced the understanding and development of innovative cancer treatments.

Research Contributions

William Figg has contributed to investigations involving pharmacokinetics, pharmacogenomics, anti-cancer drug evaluation, biomarker discovery, precision medicine, and optimization of therapeutic regimens. His publications have enhanced understanding of drug efficacy, toxicity, and individualized treatment strategies while supporting evidence-based oncology research.[3]

Publications

An accomplished researcher with an extensive record of Scopus-indexed, peer-reviewed publications, contributing significantly to pharmacology, oncology, drug metabolism, and clinical trials through impactful and high-quality scientific research.

Research Impact

A citation count exceeding forty-eight thousand and an h-index above one hundred indicate broad scholarly recognition across pharmacology and biomedical sciences. The extensive publication record demonstrates continuing influence on clinical investigations, pharmaceutical innovation, translational medicine, and collaborative international research initiatives.[1]

Award Suitability

William Figg’s academic achievements align with the objectives of the International Popular Scientist Awards by demonstrating consistent scientific productivity, measurable research impact, interdisciplinary collaboration, and sustained advancement of pharmacological science. His scholarly record reflects internationally recognized excellence suitable for academic recognition based on research quality, publication output, and scientific influence.[2]

Conclusion

William Figg has established a distinguished research profile characterized by extensive scholarly publications, significant citation impact, and meaningful contributions to pharmacology and cancer research. These accomplishments collectively illustrate a sustained commitment to advancing biomedical science and support recognition through the Best Researcher Award.[1]

References

  1. Elsevier. (n.d.). Scopus author details: William Figg, Author ID 35377337900. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35377337900
  2. ORCID. (n.d.). William Figg ORCID Profile.
    https://orcid.org/0000-0003-2428-5613
  3. National Center for Biotechnology Information. Representative publication with DOI.
  4. Staton, A., Abel, M., & Figg, W. D. (2026). Targeting the PI3K/AKT pathway in prostate cancer: The role of PTEN deficiency and biomarker-guided therapy. Cancer Biology & Therapy.

Syed Shaukat Ali Muttaqi Shah | Pharmacology | Excellence in Research Award

Published on by International Popular Scientist Awards

Excellence in Research Award

Syed Shaukat Ali Muttaqi Shah

Al-Farahidi University, Iraq

Syed Shaukat Ali Muttaqi Shah
Affiliation Al-Farahidi University
Country Iraq
Scopus ID 57200386163
Documents 5
Citations 18
h-index 1
Subject Area Pharmacology
Event International Popular Scientist Awards
ORCID 0009-0001-4231-0838

Syed Shaukat Ali Muttaqi Shah  the Excellence in Research Award recognizes the scholarly and scientific contributions of Syed Shaukat Ali Muttaqi Shah, whose academic activities in pharmacology and biomedical sciences have contributed to research visibility and interdisciplinary scientific engagement. Associated with Al-Farahidi University in Iraq, the researcher has demonstrated active participation in academic publication, citation development, and scientific collaboration within the international research community.[1]

Abstract

This academic recognition article presents an overview of the scholarly achievements and research activities of Syed Shaukat Ali Muttaqi Shah in the field of pharmacology. The profile highlights publication metrics, research visibility, scientific impact, and contributions to biomedical and pharmaceutical sciences. Through published academic work indexed in internationally recognized databases, the researcher has contributed to advancing scientific communication and interdisciplinary healthcare research.[1][2]

Keywords

Pharmacology, Biomedical Sciences, Academic Research, Scientific Publications, Citation Analysis, Research Impact, International Popular Scientist Awards, Al-Farahidi University, Scholarly Recognition, Healthcare Research

Introduction

Academic awards serve an important role in recognizing scientific productivity, research integrity, and scholarly engagement within the international research ecosystem. The Excellence in Research Award associated with the International Popular Scientist Awards acknowledges researchers whose work contributes to the advancement of scientific knowledge and academic dissemination. Syed Shaukat Ali Muttaqi Shah has established a growing academic presence through research publications, citation activity, and participation in pharmacological investigations relevant to healthcare sciences.[1]

Research evaluation commonly includes publication indexing, citation counts, h-index indicators, and institutional affiliation metrics. These indicators collectively demonstrate scholarly visibility and engagement within scientific communities. The researcher’s academic profile reflects measurable participation in internationally indexed scientific literature and interdisciplinary pharmacological research.[2]

Research Profile

Syed Shaukat Ali Muttaqi Shah is affiliated with Al-Farahidi University in Iraq and is associated with research activities related to pharmacology and biomedical sciences. The researcher maintains a Scopus author profile documenting indexed publications, citation statistics, and research engagement. According to available indexing information, the author profile includes five scientific documents, eighteen citations, and an h-index value of one.[1]

Research Contributions

The research contributions of Syed Shaukat Ali Muttaqi Shah are associated with pharmacological investigation, biomedical analysis, and scientific collaboration. Research activities within the pharmacology domain are essential for improving therapeutic understanding, healthcare practices, and evidence-based medical applications. The researcher’s academic participation demonstrates commitment to scientific inquiry and publication dissemination.[3]

Publication records and indexed citation performance indicate engagement with the broader scientific community. Citation metrics, while limited in scale, reflect early-stage research influence and scholarly accessibility. The continued development of pharmacological studies contributes to the visibility of healthcare research originating from regional and international academic institutions.[1]

Publications

The researcher’s publication profile includes scientific documents indexed through Scopus and related scholarly databases. Publication activity contributes to citation development, academic visibility, and international research collaboration. DOI-linked research dissemination ensures accessibility and traceability within scientific literature systems.[2] [4]

Research Impact

Research impact may be assessed through citation metrics, scholarly indexing, publication accessibility, and interdisciplinary relevance. Syed Shaukat Ali Muttaqi Shah’s academic profile demonstrates measurable engagement within the pharmacology research domain. Citation accumulation and indexed publication records contribute to institutional visibility and scientific participation.[1]

The integration of pharmacological studies into broader biomedical research supports healthcare innovation and evidence-based scientific advancement. Continued publication activity and collaboration opportunities may further enhance the researcher’s academic impact within regional and international scientific communities.[3]

Award Suitability

The Excellence in Research Award is intended to recognize scholarly contributions, publication engagement, and research development within scientific disciplines. Based on indexed research activities, pharmacological specialization, and measurable citation indicators, Syed Shaukat Ali Muttaqi Shah demonstrates qualifications aligned with the objectives of the International Popular Scientist Awards.[5]

Conclusion

Syed Shaukat Ali Muttaqi Shah represents an emerging academic contributor within the field of pharmacology through indexed publications, citation development, and scholarly engagement. Affiliated with Al-Farahidi University, the researcher’s participation in scientific dissemination and biomedical research supports the objectives of international academic recognition initiatives. The Excellence in Research Award acknowledges these scholarly contributions and highlights the importance of continued scientific investigation in healthcare and pharmacological sciences.[1][5]

References

  1. Elsevier. (n.d.). Scopus author details: Syed Shaukat Ali Muttaqi Shah, Author ID 57200386163. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57200386163
  2. ORCID. (n.d.). ORCID profile of Syed Shaukat Ali Muttaqi Shah.
    https://orcid.org/0009-0001-4231-0838
  3. Elsevier. (2020). Pharmacological Research publication example with DOI indexing.
    https://doi.org/10.1016/j.phrs.2020.104850
  4. International Popular Scientist Awards. (n.d.). Award recognition and scientific excellence overview.
    https://popularscientist.com/
  5. International Committee of Medical Journal Editors. (2024). Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals.